- Home
- CRIS vs CCM Comparison
CRIS vs CCM Comparison
Compare CRIS & CCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRIS
- CCM
- Stock Information
- Founded
- CRIS 2000
- CCM 1997
- Country
- CRIS United States
- CCM China
- Employees
- CRIS N/A
- CCM N/A
- Industry
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- CCM Medical/Nursing Services
- Sector
- CRIS Health Care
- CCM Health Care
- Exchange
- CRIS Nasdaq
- CCM Nasdaq
- Market Cap
- CRIS 22.9M
- CCM 23.8M
- IPO Year
- CRIS 2000
- CCM 2009
- Fundamental
- Price
- CRIS $1.61
- CCM $5.26
- Analyst Decision
- CRIS Strong Buy
- CCM
- Analyst Count
- CRIS 2
- CCM 0
- Target Price
- CRIS $16.50
- CCM N/A
- AVG Volume (30 Days)
- CRIS 72.1K
- CCM 40.0K
- Earning Date
- CRIS 11-13-2025
- CCM 09-26-2025
- Dividend Yield
- CRIS N/A
- CCM N/A
- EPS Growth
- CRIS N/A
- CCM N/A
- EPS
- CRIS N/A
- CCM N/A
- Revenue
- CRIS $11,405,000.00
- CCM $51,056,841.00
- Revenue This Year
- CRIS $2.72
- CCM N/A
- Revenue Next Year
- CRIS $8.27
- CCM N/A
- P/E Ratio
- CRIS N/A
- CCM N/A
- Revenue Growth
- CRIS 12.24
- CCM N/A
- 52 Week Low
- CRIS $1.02
- CCM $3.80
- 52 Week High
- CRIS $5.27
- CCM $10.77
- Technical
- Relative Strength Index (RSI)
- CRIS 50.58
- CCM 43.92
- Support Level
- CRIS $1.49
- CCM $4.42
- Resistance Level
- CRIS $1.63
- CCM $6.96
- Average True Range (ATR)
- CRIS 0.10
- CCM 0.61
- MACD
- CRIS 0.01
- CCM -0.11
- Stochastic Oscillator
- CRIS 68.87
- CCM 32.92
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.